Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. (a foreign private issuer) is dated September 10, 2020. The document serves as a notice regarding the Company's 2020 Annual General Meeting of Shareholders, scheduled for October 19, 2020, at its offices in Rehovot, Israel. The record date for shareholders entitled to vote is September 10, 2020.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance notice and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document focuses solely on the logistics and agenda of the upcoming shareholder meeting.
Guidance, Outlook, and Risks
The filing incorporates by reference a Proxy Statement (Exhibit 99.2) which contains details on proposals, board of directors, corporate governance, and significant shareholders. However, the text of this specific Form 6-K does not include management commentary, financial guidance, specific risk factors, or unusual items.
Key Facts for Investors to Verify
- The Annual General Meeting is scheduled for October 19, 2020, at 3:00 p.m. Israel time.
- Shareholders of record as of September 10, 2020, are eligible to vote.
- Details on voting procedures and specific proposals are located in the attached Proxy Statement (Exhibit 99.2).
- The filing incorporates exhibits into the Company's Registration Statements on Form F-3 and Form S-8.